Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Once-A-Day Pregabalin For Partial Seizures

ClinicalTrials.gov ID: NCT01262677

Public ClinicalTrials.gov record NCT01262677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin Controlled Release Formulation As Adjunctive Therapy In Adults With Partial Onset Seizures

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Approximately 30% percent of subjects with partial seizures are refractory to treatment with single or combination antiepileptic drugs. The present study will compare the efficacy of two different dosages of pregabalin CR dosed once daily as compared to placebo, when used as adjunctive therapy in subjects requiring adjunctive therapy for partial onset epilepsy, using a randomized, parallel group design.

Study identification

NCT ID
NCT01262677
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
325 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 17, 2011 (Actual)
Primary completion
Jul 31, 2012 (Actual)
Completion
Aug 1, 2012 (Actual)
Last update posted
Jan 25, 2021

2011 – 2012

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
18
Facility City State ZIP Site status
Neurology Clinic, PC Northport Alabama 35476 —
NEA Baptist Clinic Jonesboro Arkansas 72401 —
Clinical Trials, Inc. Little Rock Arkansas 72205 —
Collaborative Neuroscience Network, Inc. Long Beach California 90806 —
Viking Clinic Research Center Murrieta California 92562 —
Viking Clinical Research Center Murrieta California 92562 —
Neurological Research Institute Santa Monica California 90404 —
Viking Clinical Research Center Temecula California 92591 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Optima Neurological Services, LLC Gainesville Florida 32608 —
Sleep Disorders Center of Georgia - Gainesville Gainesville Georgia 30501 —
Southern Illinois University School of Medicine Springfield Illinois 62702 —
VCMA Comprehensive Epilepsy Center Wichita Kansas 67214 —
Via Christi Research Wichita Kansas 67214 —
Associates in Neurology, PSC Lexington Kentucky 40513 —
Mid Atlantic Headache Institute Pikesville Maryland 21208 —
Asheville Neurology Specialists, PA Asheville North Carolina 28806 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Mark A. Fisher, M.D.- Private Practice Oklahoma City Oklahoma 73112 —
Sooner Clinical Research Oklahoma City Oklahoma 73112 —
Veroniqe Sebastian, MD Oklahoma City Oklahoma 73120 —
Angelique Barreto, MD Oklahoma City Oklahoma 73135 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
FutureSearch Trials of Neurology Austin Texas 78731 —
Scott and White Healthcare-Office of Sponsored Research Administration Temple Texas 76502 —
Scott & White Healthcare Temple Texas 76508 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01262677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 25, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01262677 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →